Boots sparks price war with drug cuts

Boots has sparked a prescription price war with smaller pharmacies by slashing the cost of some of the most popular medicines by as much as 31%.

The pricing structure, which comes into effect from Friday, will see consumers pay an average of 25% less for the 10 most expensive prescription medicines.

The pharmacy giant said people living with chronic conditions such as asthma or cardiovascular disease and who were not eligible for the GMS medical card scheme would benefit most.